Showing results (351-360 of 583) with videos related to
Sort By:
Pageof 59
Infection and Immunity|May 1, 1985
Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coliJ P Nataro, I C Scaletsky, J B Kaper, et al.Infection and Immunity|May 19, 2010
Effect on human cells of environmental Vibrio parahaemolyticus strains carrying type III secretion system 2Greta Caburlotto, Maria M Lleò, Tamara Hilton, et al.Elife|July 8, 2025
Forward genetics in <i>C. elegans</i> reveals genetic adaptations to polyunsaturated fatty acid deficiencyDelaney Kaper, Uroš Radović, Per-Olof Bergh, et al.Vaccine|July 22, 2008
c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infectionAbiodun D Ogunniyi, James C Paton, Alun C Kirby, et al.Journal of Clinical Microbiology|June 10, 1998
Virulence properties of Shiga toxin-producing Escherichia coli (STEC) strains of serogroup O118, a major group of STEC pathogens in calvesL H Wieler, A Schwanitz, E Vieler, et al.International Journal of Medical Microbiology : IJMM|October 10, 2006
Identification and characterization of "pathoadaptive mutations" of the cadBA operon in several intestinal Escherichia coliJoerg Jores, Alfredo G Torres, Sylke Wagner, et al.Infection and Immunity|December 1, 1995
Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coliJ A Girón, F Qadri, T Azim, et al.Microbiology (Reading, England)|May 1, 1994
recA mutations reduce adherence and colonization by classical and El Tor strains of Vibrio choleraeK K Kumar, R Srivastava, V B Sinha, et al.The Journal of Infectious Diseases|October 1, 1983
Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containmentM M Levine, J B Kaper, H Lockman, et al.The Pediatric Infectious Disease Journal|September 1, 1987
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cellsJ P Nataro, J B Kaper, R Robins-Browne, et al.Pageof 59